Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.72 - $29.94 $5,915 - $6,886
-230 Reduced 6.83%
3,136 $85,000
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $2,412 - $3,269
103 Added 3.16%
3,366 $104,000
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $373,105 - $478,864
-22,695 Reduced 87.43%
3,263 $68,000
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $386,988 - $517,174
23,800 Added 1102.87%
25,958 $442,000
Q4 2022

Feb 14, 2023

SELL
$16.98 - $23.15 $147,556 - $201,173
-8,690 Reduced 80.11%
2,158 $43,000
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $44,265 - $59,805
-2,120 Reduced 16.35%
10,848 $233,000
Q2 2022

Aug 09, 2022

SELL
$17.07 - $25.71 $167,576 - $252,395
-9,817 Reduced 43.09%
12,968 $255,000
Q1 2022

May 13, 2022

SELL
$20.42 - $28.13 $151,189 - $208,274
-7,404 Reduced 24.53%
22,785 $535,000
Q4 2021

Feb 09, 2022

SELL
$25.89 - $33.45 $495,948 - $640,768
-19,156 Reduced 38.82%
30,189 $822,000
Q3 2021

Nov 15, 2021

BUY
$22.46 - $29.47 $1.11 Million - $1.45 Million
49,345 New
49,345 $1.36 Million
Q1 2021

May 14, 2021

SELL
$32.28 - $44.3 $74,566 - $102,333
-2,310 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$31.45 - $40.54 $4,371 - $5,635
139 Added 6.4%
2,310 $76,000
Q3 2020

Nov 13, 2020

BUY
$26.0 - $34.5 $56,446 - $74,899
2,171 New
2,171 $69,000
Q2 2020

Aug 13, 2020

SELL
$14.11 - $29.42 $44,009 - $91,760
-3,119 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$13.63 - $33.98 $42,511 - $105,983
3,119 New
3,119 $49,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.